|
|
 |
|
Viewing report
|
|
|
|
Ablynx NV (ABLX) - Financial and Strategic Analysis Review
GlobalData, Aug 2010, Pages: 35
Ablynx NV (Ablynx) is a biopharmaceutical company engaged in the discovery and development of Nanobodies, for the treatment of serious and life-threatening human diseases. Nanobodies are a novel class of antibody-derived therapeutic proteins, which have the advantages of conventional antibody along with the key features of small molecule drugs. Ablynx possesses the intellectual property rights for the commercialization of Nanobodies based products. The company's product pipeline consists of over 20 Nanobody-based therapeutic candidates. It is developing products in cardiovascular, inflammation, musculoskeletal, neurology, pulmonary and oncology therapeutic areas.
Ablynx NV Key Recent Developments
Aug 25, 2010 Ablynx Reports Net Loss Of EUR15.3 Million For H1 2010
Jul 27, 2010 Ablynx's Chief Scientific Officer Debbie Law Resigns
Jul 05, 2010 Ablynx Receives EUR1.5 Million In Grants
Jun 22, 2010 Ablynx Expands Into New R&D Facilities In Belgium
Jun 22, 2010 Ablynx Moves Into New R&D Facilities In Belgium
This comprehensive SWOT profile of Ablynx NV provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including,
- Business description - A detailed description of the company’s operations and business divisions.
- Corporate strategy - Analyst’s summarization of the company’s business strategy.
- SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history - Progression of key events associated with the company.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Executive biographies - A brief summary of the executives’ employment history.
- Key operational heads - A list of personnel heading key departments/functions.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities - A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note-: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include,
You get detailed information about the company and its operations to identify potential customers and suppliers.
-The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key
competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered
in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and
efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Customers who bought this item also bought
Ablynx NV (ABLX) - Financial and Strategic SWOT Analysis Review
Ablynx NV - Product Pipeline Review - Q4 2010
Ablynx NV - Product Pipeline Review - Q4 2010
Pharming Group N.V. (PHARM) - Financial and Strategic SWOT Analysis Review
Crucell N.V. (CRXL) - Financial and Strategic SWOT Analysis Review
Merck Serono S.A. - Strategic SWOT Analysis Review
Hunter Douglas N.V. (HDG) - Financial and Strategic SWOT Analysis Review
ThromboGenics NV (THR) - Financial and Strategic SWOT Analysis Review
Essent N.V. - Power Plants and SWOT Analysis, 2011 Update
N.V. Nuon Energy - Overview, Contact Details, Locations, Key executives, Power Plant Information, Business Description and SWOT Analysis
|
|
|
|
